एपीए उद्धरण

Nucera, C. (2019). A novel combined targeted therapy with bromodomain antagonist and MEK inhibitor in anaplastic thyroid cancer. Oncotarget.

शिकागो स्टाइल उद्धरण

Nucera, Carmelo. "A Novel Combined Targeted Therapy With Bromodomain Antagonist and MEK Inhibitor in Anaplastic Thyroid Cancer." Oncotarget 2019.

एमएलए उद्धरण

Nucera, Carmelo. "A Novel Combined Targeted Therapy With Bromodomain Antagonist and MEK Inhibitor in Anaplastic Thyroid Cancer." Oncotarget 2019.